Tag: option

Phoenix, AZ, June 18, 2026 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) achieved Fiscal First Quarter Consolidated Net Income profitability of $74,702, which is a modest improvement of $35,672, over the prior year Fiscal First Quarter. IHT reported record Hotel Revenue results of approximately $2.2 million in the Fiscal First Quarter of 2027 (February 1, 2026, to April 30, 2026).

WHEATON, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (“Innovator”), the investment adviser for the Innovator Gradient Tactical Rotation Strategy ETF and Innovator Hedged Nasdaq-100 ETF (each, a “Fund” and collectively, the “Funds”), announced today that the Funds’ Board of Trustees, at the recommendation of Innovator, has approved a plan of liquidation for each Fund (collectively, the “Plans”). Under the Plans, which are effective as of June 17, 2026, the Funds will begin the process of liquidating portfolio assets and unwinding their affairs in an orderly fashion over time. The Plans are not subject to shareholder approval.

WATERTOWN, Mass. and CINCINNATI, June 18, 2026 (GLOBE NEWSWIRE) -- Constantiam Biosciences and Cincinnati Children's today announced a strategic collaboration through an exclusive option for future licensing rights to advance first-in-class small-molecule treatments for neuronopathic Gaucher disease (Types 2 and 3).

MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- SolSource Solutions (“SolSource”) today announced that Propel, its simplified prepaid third-party ownership (TPO) financing product for residential solar and battery storage, is now available in Pennsylvania and Colorado.

REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were offered by Alvotech. Before deducting the underwriting discounts and commissions and offering expenses, the aggregate gross proceeds to the Company were approximately $98 million.

Vilmorin & Cie announces the signing of a new RCF of up to €450 million. Combined with the loan granted by the European Investment Bank, Vilmorin & Cie has therefore secured €750 million in new financing to support its growth strategy.